POTOMAC, MD / ACCESS Newswire / July 10, 2025 / IGC Pharma, Inc. (NYSE American:IGC) a clinical-stage biopharmaceutical company focused on Alzheimer's disease, today announced the development of ...

IGC Pharma Inc (IGC), with a market capitalization of $24.39 million, reported its second-quarter 2025 earnings, focusing on strategic developments in Alzheimer’s research and operational ...

The 75-year-old – who’s not sure how he gets his sound – almost gave up playing when Gibson discontinued the ES-125. Now he ...

Get the latest IGC Pharma, Inc. (IGC) stock news and headlines to help you in your trading and investing decisions.

IGC Pharma, Inc. (IGC) delivered earnings and revenue surprises of +50.00% and +6.45%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

IGC Pharma: Fiscal Year 2025 Financial and Operational Highlights - A Year of Transformative Progress in Alzheimer's Innovation Provided by ACCESS Newswire Jun 30, 2025, 6:00:00 AM ...

IGC Pharma to Host Fiscal Year-End 2025 Shareholder Update Call on Monday June 30, 2025 Provided by ACCESS Newswire Jun 27, 2025, 5:30:00 AM ...

Two prototype digital platforms—the Bangladesh Energy Dashboard (BED) and the Bangladesh Social Protection Dashboard (BSD)—were unveiled today to enhance access to timely, policy-relevant data.

Using Chris Buck’s ’50s Epiphone Flying V, Huw Price demonstrates how you can take an affordable Epiphone and transform it ...

The IGC forecasts global grain output at 2.313 billion metric tons in the 2024-25 season, up three million tons from May’s estimate. This would be a record high, just above 2023-24’s estimated ...